Biofire Joint Infection (JI) Panel

The BioFire joint infection panel also known as BJI Panel test, enhances joint infection diagnosis by providing reliable results and detects a range of pathogens and antimicrobial resistance gene targets via synovial fluid sample testing. The Biofire Panel is performed using a FDA-Approved Biofire System by Rapid Multiplex PCR method which produces an average of 91.7% sensitivity and 99.8% specificity for pathogens, with a same-day reporting TAT for samples collected before 11AM at HOD.

Please find the parameters below and a sample report attached for demonstration.